|
|
|
LifeScienceHistory.com - Check us out on Instagram
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Adverum Biotechnologies, Inc.
| | | Phone: | (650) 272-6269 | Year Established: | 2006 | Ticker: | ADVM | Exchange: | NASDAQ | Main Contact: | Leone Patterson, President, CEO & CFO | | Other Contacts: | Jennifer Cheng, PhD, JD, VP & General Counsel Mehdi Gasmi, Ph.D., CTO & CSO Linda Neuman, M.D., M.B.A, Interim CMO
| | Company Description | Adverum is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases. Adverum has a robust pipeline that includes product candidates designed to treat rare diseases alpha-1 antitrypsin (A1AT) deficiency and hereditary angioedema (HAE) as well as wet age-related macular degeneration (wAMD). | |
|
|
|
|
|